Chemerin levels have also been shown to be higher in obesity, some features of MetS, diabetes, and nonalcoholic fatty liver disease [46–48], and it appears to induce insulin resistance in skeletal muscle, the major site of peripheral insulin resistance [49]. This evidence concerns the gene RARRES2 and obesity due to melanocortin 4 receptor deficiency.